PPARγ-sparing thiazolidinediones as insulin sensitizers. Design, synthesis and selection of compounds for clinical development

Bioorg Med Chem. 2018 Dec 1;26(22):5870-5884. doi: 10.1016/j.bmc.2018.10.033. Epub 2018 Nov 2.
No abstract available

MeSH terms

  • Dose-Response Relationship, Drug
  • Drug Design*
  • Humans
  • Insulin Resistance*
  • Molecular Structure
  • PPAR gamma / agonists*
  • PPAR gamma / metabolism
  • Structure-Activity Relationship
  • Thiazolidinediones / chemical synthesis
  • Thiazolidinediones / chemistry
  • Thiazolidinediones / pharmacology*

Substances

  • PPAR gamma
  • Thiazolidinediones